Over There: Sanofi-Aventis Details Plans for Emerging Markets
This article was originally published in The Pink Sheet Daily
Executive Summary
Citing a "competitive advantage," Sanofi aims to double sales in new markets from €6.5 billion in 2008 to €17 billion by 2013.